It is now well established that practically all initial attacks and subsequent recurrences of rheumatic fever are precipitated by antecedent Group A hemolytic streptococcal infection. Evidence to support this concept has been based on the close epidemiologic and bacteriologic association of acute rheumatic fever and streptococcal infection (1) (2) (3) (4) (5) (6) (7) (8) (9) as well as on the striking similarity of the antibody responses in both of these conditions (10) . Despite this dependence of the rheumatic state upon prior hemolytic streptococcal infection, only a small portion of those exposed to this group of organisms actually develop rheumatic fever. Such disparity in the disease incidence indicates the importance of the host factor and suggests that susceptibility variables are important determinants of pathogenesis of rheumatic fever.
The purpose of this report is to explore the possibility that there exists in subjects with rheumatic fever a peculiarity of immune response which predisposes to the rheumatic state. Others have shown that hemolytic streptococcal respiratory infection complicated by rheumatic fever is associated with higher mean antistreptococcal antibody titers than is the uncomplicated illness (11, 12) , and the conclusion from such data has Deen that an immunologic hyperreactivity in such susceptible individuals may be fundamental for the development of rheumatic fever. Our studies have aimed to determine whether such supposed immunologic hyperreactivity of rheumatic subjects is confined to the streptococcus alone or whether one may also detect a more general augmentation of antibody response to non-streptococcal antigens as well. Typhoid immunization: In a second series of experiments, fourteen children with rheumatic heart disease, hospitalized at the House of the Good Samaritan, were given a single 0.1 cc. intradermal dose of monovalent typhoid vaccine containing 100 million heat-killed organisms. As controls, ten children of comparable age with Legg-Perthes disease, hospitalized at the New England Peabody Home for Crippled Children, were similarly immunized. These children showed no evidence of rheu--matic fever either by history or by physical examination. Other than mild local discomfort at the site of injection. there were no temperature elevations, no elevations in sedimentation rate, nor other untoward reactions in any of the-subjects. In addition to a control blood sample- (16) .
RESULTS
Influenza immunization: Since many of the subjects in both the rheumatic fever and control groups showed moderately high antibody levels prior to immunization, the antibody response attained after immunization has been plotted in terms of the fold increase produced by immunization (Figure 1 ). The scatter diagram in Figure 1 A presentation of antibody data in terms of fold increase omits consideration of the effect of the pre-immunization titer on the final level attained. In general, the higher the initial titer, the less the fold increase following immunization. In Table I peak levels of response were reached after two weeks in both the rheumatic subjects and in the controls. As in the influenza studies, there is much overlapping in Figure 2 between the two groups with no clear cut difference in antibody response shown by the rheumatic fever patients.
Similarly with the anti-O agglutinin ( Figure 3 ) there was extensive overlapping of individual subjects of both groups. While the general height of antibody level attained for the 0-agglutinin was moderately lower than the H-agglutinin for both control subjects. Likewise, the geometric mean of all the observations without regard for time interval after immunization is higher for the rheumatic fever patients. In Figure 5 , the geometric means of the 0-agglutinin titers for the rheumatic subjects were also somewhat higher than for the control subjects. These overall mean differences were found to be statistically significant.4
DISCUSSION
The results of these immunization studies do not confirm the hypothesis that rheumatic fever subjects show a general hyperreactivity of immune response, at least as judged by their response to the non-streptococcal antigenic stimuli of influenza virus and typhoid vaccine. In the instance of influenza virus immunization, initially elevated antibody levels prior to immunization may have obscured true differences of response from a uniform baseline, and for this reason typhoid immunization was considered to be a more valid method of studying these young subjects in the unsensitized state. None of the particular children immunized gave a history of previous typhoid infection or typhoid immunization, and baseline agglutinin levels confirmed the absence of typhoid antibodies. Although statistically significant, the observed difference between the mean titers is rather small and clinical conclusions of general hyperreactivity of rheumatic subjects appear hazardous. Also, the relatively small number of cases studied may hold for these particular individuals and not for rheumatic subjects in general.
A recent report by Creger, Choy, and Rantz (17) in which similar immunization studies, using mismatched blood, resulted in more striking increases of antibody response by rheumatic subjects warrants comment. Of the three rheumatic subjects demonstrating hyperreactivity of response to heterologous blood cells, the one subject showing the greatest rise in isoagglutinins had received a previous injection of mismatched blood and hence the response may have been, in part at least, the manifestation of a "booster phenomenon." Further, the use to heterologous blood substances prior to challenge suggests that the criterion of an unsensitized state does not truly exist. Thus, even the first dose of group B cells given to a group A individual represents a "booster challenge" to the production of isoagglutinins.
On the other hand, the use of such antigenic boosters in previously sensitized persons may be the more appropriate means of detecting immunologic hyperreactions especially as related to hypersensitivity theories of rheumatic fever pathogenesis. If, as many have postulated, rheumatic fever develops in susceptible individuals only after repeated exposure to the hemolytic streptococcus, the experimental results of Creger, Choy, and Rantz are corroborating evidence. The work of Murphy and Swift (18) in animals is also in accord with such reasoning. It could follow that reimmunization of our subjects with repeated doses of typhoid vaccine might then result in more striking differences of antibody response and that such booster stimuli by the same antigen might ultimately demonstrate a more significant augmentation of immune response in rheumatic fever subjects. In the absence of such data and on the basis of our results with influenza and typhoid vaccines, however, it seems unwarranted to attribute any striking hyperreactivity of response to these antigens in the rheumatic subjects tested.
Such discrepancies of antibody response in somewhat comparable studies emphasize the lack of a uniform pattern of host hyperreactivity in rheumatic fever. Increased numbers of observations using varied measurements of immunologic indices, will be necessary before it is possible to define the role of immune responsiveness in rheumatic fever susceptibility. SUMMARY 1. Twenty-three children in the convalescent stage of rheumatic fever were immunized with either polyvalent influenza virus vaccine or with monovalent typhoid vaccine. Twenty-eight nonrheumatic children of comparable age were similarly immunized and served as controls.
2. Results of influenza immunization, using complement fixing and hemagglutination inhibiting antibodies as indices of response, showed a wide variation in titer with no essential difference between the two groups.
3. Whereas the geometric mean antibody to typhoid vaccine was slightly higher in rheumatic fever patients, there was extensive overlapping and scattering of individual responses in both groups over the eight week period of study. 4. On the basis of these observations using both a viral and bacterial antigen, it seems unwarranted to attribute to these rheumatic individuals any general hyperreactivity of immune response as an explanation for the development of the rheumatic state.
